New structural insights into the multi ‐functional influenza A matrix protein 1

AbstractInfluenza A virus matrix protein 1 (M1) is the most abundant protein within virions and functions at multiple steps of the virus life cycle, including nuclear RNA export, virus particle assembly, and virus disassembly. Two recent publications have presented the first structures of full-length M1, and show that it assembles filamentsin vitro via an interface between the N- and C- terminal domains of adjacent monomers. These filaments were found to be similar to those that form the endoskeleton of assembled virions. The structures provide a molecular basis to understand the functions of M1 during the virus life cycle. Here we compare and discuss the two structures, and explore their implications for the mechanisms by which the multifunctional M1 protein can mediate virus assembly, interact with viral ribonucleoproteins and act during infection of a new cell.
Source: FEBS Letters - Category: Biochemistry Authors: Tags: Review Article Source Type: research

Related Links:

Background: Recurrent acute otitis media in the first years of life can be explained by immune dysfunction. Consequently, it would be expected that otitis-prone (OP) children would be more susceptible to other infectious diseases, especially respiratory infections, since a component of the immune problem involves nasopharyngeal innate immunity. Design: Cohort study with prospective identification of all physician-diagnosed, medically attended respiratory illness visits in children 6 months to 5 years of age to determine the incidence of pneumonia, acute sinusitis, influenza and other bacterial and viral infectio...
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Original Studies Source Type: research
' This approval officially allows all eligible Americans to receive a cell-based influenza vaccine, increasing the potential for greater vaccine effectiveness. 'FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Pediatrics News Alert Source Type: news
Conditions:   Influenza;   Herpes Zoster Interventions:   Biological: Herpes zoster vaccination (Shingrix, GSK);   Biological: Influenza Vaccine (Fluarix Tetra Northern Hemisphere 2021, GSK);   Biological: Placebo Sponsors:   Radboud University;   GlaxoSmithKline Recruiting
Source: - Category: Research Source Type: clinical trials
Rapid tests to identify infectious agents can be highly useful since, in principle, they allow decisions to be made at the site of care (Point-of-Care, POC) for treatment selection, or for the separation of cohorts to avoid cross-infection. Rapid tests are especially useful in emergency situations, such as those currently being experienced in the context of the COronaVIrus Disease 19 (COVID-19) pandemic. For influenza and other respiratory viruses, rapid tests are readily available and have shown clinical benefits (Benirschke et al., 2019; Rahamat ‐Langendoen et al., 2019; Shengchen et al., 2019; Wabe et al., 2019), alth...
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
Conditions:   ARDS;   COVID-19;   H1N1 Influenza Intervention:   Sponsor:   University of Turin, Italy Completed
Source: - Category: Research Source Type: clinical trials
Background: It is just over a century since the 1918 flu pandemic, sometimes referred to as the “mother” of pandemics. This brief retrospective of the 1918 pandemic is taken from the viewpoint of the current SARS-CoV-2/COVID-19 pandemic and is based on a short lecture given during the 2021 Virtual Congress of the ERA-EDTA.Summary: This review summarizes and highlights some of the earlier pandemic ’s salient features, some parallels with today, and some potential learnings, bearing in mind that the flu pandemic occurred over 100 years ago at a time of major turmoil during the climax to WWl, and with limite...
Source: Kidney and Blood Pressure Research - Category: Urology & Nephrology Source Type: research
Expert Rev Hematol. 2021 Oct 16. doi: 10.1080/17474086.2021.1995348. Online ahead of print.ABSTRACTINTRODUCTION: Drug repositioning (DR) is defined as determining new therapeutic applications for existing drugs. This approach is advantageous over de novo drug discovery in accelerating clinical development, in terms of lower costs, a shortened development period, a well-known action mechanism, a feasible dosage, and an acceptable safety profile.AREAS COVERED: This work was aimed at reviewing agents with successful DR in hematology.EXPERT OPINION: Thalidomide and plerixafor have been successfully repositioned for treating mu...
Source: Expert Review of Hematology - Category: Hematology Authors: Source Type: research
Mol Biol Evol. 2021 Oct 18:msab304. doi: 10.1093/molbev/msab304. Online ahead of print.ABSTRACTWhile some variation introgressed from Neanderthals has undergone selective sweeps, little is known about its functional significance. We used a Massively Parallel Reporter Assay (MPRA) to assay 5,353 high-frequency introgressed variants for their ability to modulate the gene expression within 170bp of endogenous sequence. We identified 2,548 variants in active putative cis-regulatory elements (CREs) and 292 expression-modulating variants (emVars). These emVars are predicted to alter the binding motifs of important immune transcr...
Source: Mol Biol Cell - Category: Molecular Biology Authors: Source Type: research
In this study, we explored the APC-targeting strategy for a PfRH5ΔNL-containing DNA vaccine. BALB/c mice immunized with the targeted vaccine induced higher PfRH5-specific IgG1 antibody responses than those vaccinated with a non-targeted vaccine or antigen alone. The APC-targeted vaccine also efficiently induced rapid IFN-γ and IL-4 T cell responses. Furthermore, the vaccine-induced PfRH5-specific IgG showed inhibition of growth of the P. falciparum 3D7 clone parasite in vitro. Finally, sera obtained after vaccination with this targeted vaccine competed for the same epitopes as PfRH5-specific mAbs from vaccinate...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
by Daniel Cresta, Donald C. Warren, Christian Quirouette, Amanda P. Smith, Lindey C. Lane, Amber M. Smith, Catherine A. A. Beauchemin The endpoint dilution assay’s output, the 50% infectious dose (ID50), is calculated using the Reed-Muench or Spearman-K ärber mathematical approximations, which are biased and often miscalculated. We introduce a replacement for the ID50 that we call Specific INfection (SIN) along with a free and open-source web-application, midSIN ( to calculate it. midSIN computes a virus sample ’s SIN concentration using Bayesian inference based on the re...
Source: PLoS Computational Biology - Category: Biology Authors: Source Type: research
More News: Biochemistry | Influenza